These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10942601)
1. Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. Bergström JD; Westermark B; Heldin NE Exp Cell Res; 2000 Aug; 259(1):293-9. PubMed ID: 10942601 [TBL] [Abstract][Full Text] [Related]
2. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB; Hota C; Wilson SM; Chambers AF Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233 [TBL] [Abstract][Full Text] [Related]
4. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857 [TBL] [Abstract][Full Text] [Related]
5. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo. Long IS; Han K; Li M; Shirasawa S; Sasazuki T; Johnston M; Tsao MS Mol Cancer Res; 2003 Mar; 1(5):393-401. PubMed ID: 12651912 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG; Ethier SP Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641 [TBL] [Abstract][Full Text] [Related]
9. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Guha S; Lunn JA; Santiskulvong C; Rozengurt E Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318 [TBL] [Abstract][Full Text] [Related]
12. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Yin F; Giuliano AE; Van Herle AJ Anticancer Res; 1999; 19(5B):4297-303. PubMed ID: 10628390 [TBL] [Abstract][Full Text] [Related]
13. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor. El-Obeid A; Hesselager G; Westermark B; Nistér M Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu C; Tsao MS Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369 [TBL] [Abstract][Full Text] [Related]
15. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells. Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629 [TBL] [Abstract][Full Text] [Related]
17. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317 [TBL] [Abstract][Full Text] [Related]
18. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Liu N; Furukawa T; Kobari M; Tsao MS Am J Pathol; 1998 Jul; 153(1):263-9. PubMed ID: 9665487 [TBL] [Abstract][Full Text] [Related]
19. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042 [TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression. Su W; Sin M; Darrow A; Sherman LS Glia; 2003 Jun; 42(4):350-8. PubMed ID: 12730955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]